Case number# PHEH2015US012692, is an initial report received on 30 Jun 2015 from a consumer (patient) via a 
patient oriented program (Gilenya Go Program, POP ID: POP00002581). This report refers to an adult female 
patient.
The patient's medical history and concomitant medication were not reported. The patient received Gilenya 
(fingolimod) capsule 0.5 mg (batch/lot number: S0108; expiration date: Nov 2016) for the treatment of multiple 
sclerosis from 2011 at a dose of 0.5 mg, QD (oral). 
The patient reported that on an unknown date (reported as 2 weeks ago) she tested positive for JC virus (JC virus 
test positive). The patient also reported that she had an MRI last Friday and was told that it was stable. Therapy 
with Gilenya was ongoing. The outcome of the event JC virus test positive was unknown. 
The seriousness and causality of the event was not reported.
Print Time: 13-JUN-2016 09:36 AM If a field is blank, there is no data for that field Page 149 of 457
FDA - Adverse Event Reporting System (FAERS) 
FOIA Case Report Information